Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Acute Coronary Syndromes

  • Article

    Apixaban plus a P2Y12 inhibitor best balances bleeding and ischemic events in patients with atrial fibrillation and recent acute coronary syndrome or percutaneous coronary intervention

    May 2, 2022

    Clinical question: Can the HAS-BLED and CHA2DS2-VASc scores be used to identify subgroups of patients with atrial fibrillation (AF) and recent acute coronary syndrome (ACS) or percutaneous coronary...

  • 1
    News

    New data on rare myocarditis after COVID-19 vaccination

    December 8, 2021

    Most adolescents and young adults recover quickly from the rare complication of myocarditis following mRNA COVID-19 vaccination, a new study shows.

  • 1
    News

    No serious CV risks for elderly after Pfizer COVID-19 vaccine

    December 2, 2021

    A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.

  • News

    Predicting cardiac shock mortality in the ICU

    November 23, 2021

    Including biventricular dysfunction as assessed using transthoracic echocardiography improves clinical risk stratification.

  • 1
    News

    Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT

    November 17, 2021

    The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.

  • 1
    News

    AHA/ACC issues first comprehensive guidance on chest pain

    October 29, 2021

    The clinical practice guideline offers a contemporary approach to determine which patients need further testing and which do not.

  • News

    Fluoroquinolones linked to sudden death risk for those on hemodialysis

    October 25, 2021

    Most patients undergoing hemodialysis have a least one risk factor for drug-induced QT interval prolongation.

  • News

    No benefit from lower temps for out-of-hospital cardiac arrest

    October 20, 2021

    The results “do not support the use of moderate therapeutic hypothermia to improve neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest.”

  • News

    Cardiogenic shock teams again tied to lower mortality

    September 23, 2021

    New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.

  • News

    Growing proportion of cardiac arrests in U.S. considered opioid related

    September 10, 2021

    Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.

1 2 3 … 11Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences